InVitae (NYSE: NVTA) reported Q3 EPS of ($0.71), $0.01 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.55 million.

For earnings history and earnings-related data on InVitae (NVTA) click here.